Clik here to view.
MIT, Brigham researchers deliver strands of RNA using ultrasound
Researchers from the Massachusetts Institute of Technology and Brigham & Women’s Hospital have developed a technique to deliver strands of RNA to colon cells using bursts of ultrasound waves. The...
View ArticleClik here to view.
Scientists develop nanoparticles to ‘suffocate’ tumor cells
A team of researchers from the Shanghai Institute of Ceramics, Chinese Academy of Sciences and the East China Normal University have developed polyvinyl pyrrolidone modified nanoparticles that serve...
View ArticleClik here to view.
7D Surgical wins FDA, Health Canada nod for spinal surgical guidance system
Canadian medical device firm 7D Surgical said today it won FDA 510(k) and Health Canada clearance for its machine-vision image guided 7D Surgical navigation system designed for spinal procedures. The...
View ArticleClik here to view.
EnteroMedics closes $19m offering
EnteroMedics (NSDQ:ETRM) said today it closed an underwritten public offering of Class A units, raising $19 million, including a fully-exercised underwriters over-allotment option. The St. Paul,...
View ArticleClik here to view.
Private Equity firms eye German prosthetic maker Ottobock
A handful of private equity groups are looking to get a piece of Germany’s Ottobock, the world’s largest maker of artificial limbs. Private equity groups KKR and CVC and buyout firms BC Partners and...
View ArticleClik here to view.
Ex-FDA commissioner Califf sees patient-groups, patient input as necessary to...
The future of the FDA will depend even more on patient groups and patient input on drug evaluation, and will need to rely more on outside watchdogs to eliminate “imposters,” according to former...
View ArticleClik here to view.
Philips slips on missed Q4 earnings, warns on AED recall repercussions
(Reuters) — Royal Philips (NYSE:PHG) missed forecasts for 4th-quarter earnings today and said a dispute with the U.S. Justice Dept. over defibrillators it sold through 2015 would significantly impact...
View ArticleClik here to view.
Report: Trump considers ex-Mela Sciences CEO Gulfo for FDA chief
A name familiar to the medical device industry has surfaced as a possible nominee to lead the FDA: the Trump administration is reportedly mulling Dr. Joseph Gulfo, the former CEO of Mela Sciences (now...
View ArticleClik here to view.
Medical device industry laws in the wake of “Hard Brexit”
By Ronald Boumans, Emergo Group In 2016, we discussed the possible options for what a Brexit could look like and what the British prime minister meant with “Brexit means Brexit.” The official date of...
View ArticleClik here to view.
Johnson & Johnson mulls ‘strategic options’ for diabetes business
Johnson & Johnson (NYSE:JNJ) said today that it’s mulling the proverbial “strategic options” for its diabetes business, including the LifeScan, Animas and Calibra Medical brands. “Strategic options...
View ArticleClik here to view.
Ocular Therapeutix looks to raise $25m in public offering
Ocular Therapeutix (NSDQ:OCUL) said today that it launched a $25 million underwritten public offering of its common stock. The Bedford, Mass.-based company did not provide any specific pricing details...
View ArticleClik here to view.
ResMed shares lift on Street-beating Q2
Shares in ResMed (NYSE:RMD) have risen in premarket trading today after the respiratory-focused device maker topped expectations on Wall Street with its 2nd quarter results. The San Diego,...
View ArticleClik here to view.
Edwards Lifesciences closes $690m Valtech Cardio buy
Edwards Lifesciences (NYSE:EW) said yesterday that it closed the $690 million buyout of Valtech Cardio and most of the heart valve repair technologies it’s developing. Valtech makes the Cardioband...
View ArticleClik here to view.
Medtronic wins CE Mark for 6F HawkOne PAD atherectomy system
Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union for a 6 French version of its HawkOne directional atherectomy device designed for treating peripheral artery disease. The...
View ArticleClik here to view.
Medtronic launches trial for Visualase MRI-Guided laser ablation device in...
Medtronic (NYSE:MDT) said today that the 1st procedure using the Visualase MRI-Guided laser ablation system has been performed in its SLATE clinical trial evaluating the device in patients with...
View ArticleClik here to view.
Report: IRS agrees to slash Medtronic’s $1.4B transfer pricing tax tab by an...
The U.S. Internal Revenue Service reportedly agreed to drastically slash the amount it claims Medtronic (NYSE:MDT) owes on loans between its subsidiaries, from a potential $1.36 billion to just $14...
View ArticleClik here to view.
Spectranetics touts high primary patency, low CD-TLR for Stellarex DCB data...
Spectranetics (NSDQ:SPNC) today released 12-month data from the Illumenate global study of its Stellarex drug-coated balloon in treating peripheral artery disease in superficial femoral and popliteal...
View ArticleClik here to view.
Vention acquires nitinol-wire component maker Lithotech Medical
Vention Medical said today that it acquired Israeli nitinol wire component maker Lithotech Medical. The acquisition grows Vention’s portfolio of advanced components and tech for the development and...
View ArticleClik here to view.
3M Health Care posts flat Q4 sales, income slides
Sales were flat and income fell for 3M‘s (NYSE:MMM) 3M Health Care business during the 4th quarter, the industrial giant said today. Operating income for the healthcare business was $410 million for...
View ArticleClik here to view.
NantKwest launches clinical trial for natural killer cells
NantKwest Inc. (NSDQ:NK) said yesterday that the FDA approved an Investigational New Drug Application for its natural killer cell therapy phase I clinical study. The company is evaluating its...
View Article